We are live on ! Find out more
CYNA

CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA

Delisted

CYNA was delisted on the 20th of October, 2016.

32 hedge funds and large institutions have $116M invested in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in 2016 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more funds holding in top 10

Funds holding in top 10: 14 (+3)

37% more capital invested

Capital invested by funds: $85.2M → $116M (+$31.3M)

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

3% more funds holding

Funds holding: 3132 (+1)

11% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 9

Holders
32
Holders Change
+1
Holders Change %
+3.23%
% of All Funds
0.85%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.11%
New
5
Increased
8
Reduced
9
Closed
4
Calls
Puts
Net Calls
Net Calls Change

CYNA Hedge Fund Activity: Q2 2016 in Review

32 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) for Q2 2016, worth a combined $116M — up 37% from $85.2M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new CYNA positions and 4 closed out — a net gain of 1 holder — while 8 added to existing stakes and 9 trimmed.

The largest buyer was Tekla Capital Management, adding an estimated $3.77M. The largest seller was Acuta Capital Partners, cutting an estimated $6.39M.

  • 32 institutional investors held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) as of Q2 2016, up from 31 in Q1 2016.
  • Funds reported $116M of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) stock for Q2 2016, up 37% quarter-over-quarter.
  • 5 funds opened new CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) positions in Q2 2016 and 4 closed out, a net change of +1 holder.
  • The largest CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) buyer in Q2 2016 was Tekla Capital Management, an estimated $3.77M added.
  • The largest CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) seller in Q2 2016 was Acuta Capital Partners, an estimated $6.39M sold.

Based on aggregated 13F filings for Q2 2016.